MARION THOMAS: Open Payments
NPI 1821720715 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 20 payments from 9 companies in 2025. Trend: 2023 $32 · 2024 $290 · 2025 $876
Food & beverage: $818Education: $58
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 7 | $486 |
| TG Therapeutics, Inc. | 3 | $177 |
| Celgene Corporation | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Biogen, Inc. | 1 | $17 |
| ARGENX US, INC. | 1 | $14 |
Products named: BRIUMVI, ZEPOSIA, KESIMPTA, ULTOMIRIS, Ocrevus Zunovo, PURIFIED CORTROPHIN GEL, TYSABRI, VYVGART HYTRULO.
Industry payments across VA — which companies pay providers there.
